Heart Drug

Show Articles
Journal Properties
  • Incorporated into
    Cardiology
  • Language
    English
  • Number of Articles
    234
  • ISSN
    1422-9528
  • e-ISSN
    1424-0556
  • Main Publisher
    Karger
  • Publisher
    S. Karger AG
  • Indian UGC
  • DOAJ (latest)
Description
Heart Drug delivers cutting-edge research on cardiovascular therapeutics, including new pharmacological agents and treatment strategies. Stay informed on the latest advances in cardiology, from molecular mechanisms to clinical trials. This journal offers a focused exploration of drug-related interventions in heart health. Coverage extends to a broad range of topics, including antiarrhythmic drugs, antihypertensive medications, and novel therapies for heart failure. It also addresses the pharmacogenomics influencing drug response, catering to cardiologists, pharmacologists, and researchers. Indexing in major databases ensures wide visibility and accessibility. Contribute your research to a journal dedicated to advancing cardiac care through innovative drug therapies. With a commitment to disseminating high-impact findings, Heart Drug provides a vital platform for researchers and clinicians alike. Submit your manuscript today and contribute to the future of cardiovascular medicine. Its open-access options also support broad dissemination of important discoveries.